nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—atopic dermatitis	0.499	0.748	CbGaD
Pseudoephedrine—TNF—atopic dermatitis	0.169	0.252	CbGaD
Pseudoephedrine—Atomoxetine—Diphenhydramine—atopic dermatitis	0.099	1	CrCrCtD
Pseudoephedrine—IL2—neck—atopic dermatitis	0.00234	0.293	CbGeAlD
Pseudoephedrine—IL2—skin of body—atopic dermatitis	0.00152	0.189	CbGeAlD
Pseudoephedrine—NFATC1—head—atopic dermatitis	0.00108	0.135	CbGeAlD
Pseudoephedrine—IL2—head—atopic dermatitis	0.00099	0.124	CbGeAlD
Pseudoephedrine—MAOA—neck—atopic dermatitis	0.00046	0.0575	CbGeAlD
Pseudoephedrine—Chest pain—Loratadine—atopic dermatitis	0.000364	0.00395	CcSEcCtD
Pseudoephedrine—Delirium—Prednisone—atopic dermatitis	0.000361	0.00391	CcSEcCtD
Pseudoephedrine—Sweating—Tacrolimus—atopic dermatitis	0.000358	0.00389	CcSEcCtD
Pseudoephedrine—Euphoric mood—Hydrocortisone—atopic dermatitis	0.000358	0.00389	CcSEcCtD
Pseudoephedrine—Body temperature increased—Pimecrolimus—atopic dermatitis	0.000346	0.00376	CcSEcCtD
Pseudoephedrine—Vertigo—Fluocinolone Acetonide—atopic dermatitis	0.000345	0.00375	CcSEcCtD
Pseudoephedrine—Bradycardia—Tacrolimus—atopic dermatitis	0.000342	0.00371	CcSEcCtD
Pseudoephedrine—Tachycardia—Loratadine—atopic dermatitis	0.000341	0.0037	CcSEcCtD
Pseudoephedrine—Euphoric mood—Triamcinolone—atopic dermatitis	0.000337	0.00366	CcSEcCtD
Pseudoephedrine—Euphoric mood—Methylprednisolone—atopic dermatitis	0.000336	0.00365	CcSEcCtD
Pseudoephedrine—Hallucination—Tacrolimus—atopic dermatitis	0.000334	0.00362	CcSEcCtD
Pseudoephedrine—Dizziness—Fluocinonide—atopic dermatitis	0.000332	0.00361	CcSEcCtD
Pseudoephedrine—Asthenia—Dimenhydrinate—atopic dermatitis	0.000325	0.00353	CcSEcCtD
Pseudoephedrine—Asthenia—Diphenhydramine—atopic dermatitis	0.000325	0.00353	CcSEcCtD
Pseudoephedrine—Rash—Fluocinonide—atopic dermatitis	0.000317	0.00344	CcSEcCtD
Pseudoephedrine—Dermatitis—Fluocinonide—atopic dermatitis	0.000317	0.00344	CcSEcCtD
Pseudoephedrine—Insomnia—Loratadine—atopic dermatitis	0.000316	0.00343	CcSEcCtD
Pseudoephedrine—Headache—Fluocinonide—atopic dermatitis	0.000315	0.00342	CcSEcCtD
Pseudoephedrine—Chest pain—Mometasone—atopic dermatitis	0.000312	0.00339	CcSEcCtD
Pseudoephedrine—Dyspepsia—Loratadine—atopic dermatitis	0.000307	0.00334	CcSEcCtD
Pseudoephedrine—Euphoric mood—Dexamethasone—atopic dermatitis	0.000306	0.00332	CcSEcCtD
Pseudoephedrine—Euphoric mood—Betamethasone—atopic dermatitis	0.000306	0.00332	CcSEcCtD
Pseudoephedrine—Arrhythmia—Tacrolimus—atopic dermatitis	0.0003	0.00325	CcSEcCtD
Pseudoephedrine—Dizziness—Dimenhydrinate—atopic dermatitis	0.0003	0.00325	CcSEcCtD
Pseudoephedrine—Dizziness—Diphenhydramine—atopic dermatitis	0.0003	0.00325	CcSEcCtD
Pseudoephedrine—Pain—Loratadine—atopic dermatitis	0.000298	0.00324	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Hydrocortisone—atopic dermatitis	0.000295	0.00321	CcSEcCtD
Pseudoephedrine—Irritability—Hydrocortisone—atopic dermatitis	0.000289	0.00314	CcSEcCtD
Pseudoephedrine—Vomiting—Dimenhydrinate—atopic dermatitis	0.000288	0.00313	CcSEcCtD
Pseudoephedrine—Vomiting—Diphenhydramine—atopic dermatitis	0.000288	0.00313	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Loratadine—atopic dermatitis	0.000288	0.00312	CcSEcCtD
Pseudoephedrine—Tension—Tacrolimus—atopic dermatitis	0.000287	0.00311	CcSEcCtD
Pseudoephedrine—Rash—Diphenhydramine—atopic dermatitis	0.000286	0.0031	CcSEcCtD
Pseudoephedrine—Rash—Dimenhydrinate—atopic dermatitis	0.000286	0.0031	CcSEcCtD
Pseudoephedrine—Anorexia—Mometasone—atopic dermatitis	0.000285	0.0031	CcSEcCtD
Pseudoephedrine—Dermatitis—Diphenhydramine—atopic dermatitis	0.000285	0.0031	CcSEcCtD
Pseudoephedrine—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000285	0.0031	CcSEcCtD
Pseudoephedrine—Headache—Diphenhydramine—atopic dermatitis	0.000284	0.00308	CcSEcCtD
Pseudoephedrine—Headache—Dimenhydrinate—atopic dermatitis	0.000284	0.00308	CcSEcCtD
Pseudoephedrine—Nervousness—Tacrolimus—atopic dermatitis	0.000284	0.00308	CcSEcCtD
Pseudoephedrine—Muscle spasms—Tacrolimus—atopic dermatitis	0.000281	0.00305	CcSEcCtD
Pseudoephedrine—Vomiting—Pimecrolimus—atopic dermatitis	0.000279	0.00302	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Methylprednisolone—atopic dermatitis	0.000278	0.00301	CcSEcCtD
Pseudoephedrine—Rash—Pimecrolimus—atopic dermatitis	0.000276	0.003	CcSEcCtD
Pseudoephedrine—Dermatitis—Pimecrolimus—atopic dermatitis	0.000276	0.003	CcSEcCtD
Pseudoephedrine—Body temperature increased—Loratadine—atopic dermatitis	0.000276	0.003	CcSEcCtD
Pseudoephedrine—Headache—Pimecrolimus—atopic dermatitis	0.000274	0.00298	CcSEcCtD
Pseudoephedrine—Tremor—Tacrolimus—atopic dermatitis	0.000274	0.00297	CcSEcCtD
Pseudoephedrine—Irritability—Methylprednisolone—atopic dermatitis	0.000271	0.00295	CcSEcCtD
Pseudoephedrine—Nausea—Dimenhydrinate—atopic dermatitis	0.000269	0.00292	CcSEcCtD
Pseudoephedrine—Nausea—Diphenhydramine—atopic dermatitis	0.000269	0.00292	CcSEcCtD
Pseudoephedrine—Agitation—Tacrolimus—atopic dermatitis	0.000268	0.00291	CcSEcCtD
Pseudoephedrine—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000268	0.00291	CcSEcCtD
Pseudoephedrine—Dyspnoea—Mometasone—atopic dermatitis	0.000267	0.0029	CcSEcCtD
Pseudoephedrine—Euphoric mood—Prednisone—atopic dermatitis	0.000266	0.00289	CcSEcCtD
Pseudoephedrine—Dyspepsia—Mometasone—atopic dermatitis	0.000264	0.00286	CcSEcCtD
Pseudoephedrine—Vertigo—Tacrolimus—atopic dermatitis	0.000262	0.00285	CcSEcCtD
Pseudoephedrine—SLC6A3—head—atopic dermatitis	0.000261	0.0327	CbGeAlD
Pseudoephedrine—Decreased appetite—Mometasone—atopic dermatitis	0.00026	0.00283	CcSEcCtD
Pseudoephedrine—Nausea—Pimecrolimus—atopic dermatitis	0.00026	0.00283	CcSEcCtD
Pseudoephedrine—Palpitations—Tacrolimus—atopic dermatitis	0.000258	0.0028	CcSEcCtD
Pseudoephedrine—Pain—Mometasone—atopic dermatitis	0.000256	0.00278	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Betamethasone—atopic dermatitis	0.000252	0.00274	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Dexamethasone—atopic dermatitis	0.000252	0.00274	CcSEcCtD
Pseudoephedrine—Hypertension—Tacrolimus—atopic dermatitis	0.000252	0.00274	CcSEcCtD
Pseudoephedrine—Asthenia—Loratadine—atopic dermatitis	0.00025	0.00272	CcSEcCtD
Pseudoephedrine—Chest pain—Tacrolimus—atopic dermatitis	0.000249	0.0027	CcSEcCtD
Pseudoephedrine—ADRB1—head—atopic dermatitis	0.000248	0.031	CbGeAlD
Pseudoephedrine—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000248	0.00269	CcSEcCtD
Pseudoephedrine—Anxiety—Tacrolimus—atopic dermatitis	0.000248	0.00269	CcSEcCtD
Pseudoephedrine—Irritability—Betamethasone—atopic dermatitis	0.000247	0.00268	CcSEcCtD
Pseudoephedrine—Irritability—Dexamethasone—atopic dermatitis	0.000247	0.00268	CcSEcCtD
Pseudoephedrine—Confusional state—Tacrolimus—atopic dermatitis	0.00024	0.00261	CcSEcCtD
Pseudoephedrine—SLC6A4—head—atopic dermatitis	0.00024	0.0299	CbGeAlD
Pseudoephedrine—Body temperature increased—Mometasone—atopic dermatitis	0.000237	0.00257	CcSEcCtD
Pseudoephedrine—Tachycardia—Tacrolimus—atopic dermatitis	0.000233	0.00253	CcSEcCtD
Pseudoephedrine—Dizziness—Loratadine—atopic dermatitis	0.000231	0.00251	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.00023	0.0025	CcSEcCtD
Pseudoephedrine—Anorexia—Tacrolimus—atopic dermatitis	0.000227	0.00247	CcSEcCtD
Pseudoephedrine—Vomiting—Loratadine—atopic dermatitis	0.000222	0.00241	CcSEcCtD
Pseudoephedrine—Rash—Loratadine—atopic dermatitis	0.00022	0.00239	CcSEcCtD
Pseudoephedrine—Psychotic disorder—Prednisone—atopic dermatitis	0.00022	0.00239	CcSEcCtD
Pseudoephedrine—Dermatitis—Loratadine—atopic dermatitis	0.00022	0.00239	CcSEcCtD
Pseudoephedrine—Headache—Loratadine—atopic dermatitis	0.000219	0.00237	CcSEcCtD
Pseudoephedrine—Bradycardia—Prednisolone—atopic dermatitis	0.000218	0.00237	CcSEcCtD
Pseudoephedrine—Insomnia—Tacrolimus—atopic dermatitis	0.000216	0.00234	CcSEcCtD
Pseudoephedrine—Asthenia—Mometasone—atopic dermatitis	0.000215	0.00233	CcSEcCtD
Pseudoephedrine—Irritability—Prednisone—atopic dermatitis	0.000215	0.00233	CcSEcCtD
Pseudoephedrine—Bradycardia—Hydrocortisone—atopic dermatitis	0.000213	0.00231	CcSEcCtD
Pseudoephedrine—Dyspnoea—Tacrolimus—atopic dermatitis	0.000213	0.00231	CcSEcCtD
Pseudoephedrine—SLC6A2—head—atopic dermatitis	0.000211	0.0264	CbGeAlD
Pseudoephedrine—Sweating—Methylprednisolone—atopic dermatitis	0.00021	0.00228	CcSEcCtD
Pseudoephedrine—Dyspepsia—Tacrolimus—atopic dermatitis	0.00021	0.00228	CcSEcCtD
Pseudoephedrine—Hallucination—Hydrocortisone—atopic dermatitis	0.000208	0.00226	CcSEcCtD
Pseudoephedrine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000207	0.00225	CcSEcCtD
Pseudoephedrine—Nausea—Loratadine—atopic dermatitis	0.000207	0.00225	CcSEcCtD
Pseudoephedrine—Decreased appetite—Tacrolimus—atopic dermatitis	0.000207	0.00225	CcSEcCtD
Pseudoephedrine—Pain—Tacrolimus—atopic dermatitis	0.000204	0.00221	CcSEcCtD
Pseudoephedrine—Bradycardia—Triamcinolone—atopic dermatitis	0.000201	0.00218	CcSEcCtD
Pseudoephedrine—Bradycardia—Methylprednisolone—atopic dermatitis	0.0002	0.00217	CcSEcCtD
Pseudoephedrine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000199	0.00217	CcSEcCtD
Pseudoephedrine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000198	0.00215	CcSEcCtD
Pseudoephedrine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000198	0.00215	CcSEcCtD
Pseudoephedrine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000196	0.00213	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000196	0.00213	CcSEcCtD
Pseudoephedrine—ADRA1A—head—atopic dermatitis	0.000196	0.0245	CbGeAlD
Pseudoephedrine—Hallucination—Methylprednisolone—atopic dermatitis	0.000196	0.00212	CcSEcCtD
Pseudoephedrine—MAOA—head—atopic dermatitis	0.000194	0.0243	CbGeAlD
Pseudoephedrine—Arrhythmia—Prednisolone—atopic dermatitis	0.000191	0.00208	CcSEcCtD
Pseudoephedrine—Vomiting—Mometasone—atopic dermatitis	0.00019	0.00207	CcSEcCtD
Pseudoephedrine—Rash—Mometasone—atopic dermatitis	0.000189	0.00205	CcSEcCtD
Pseudoephedrine—Dermatitis—Mometasone—atopic dermatitis	0.000189	0.00205	CcSEcCtD
Pseudoephedrine—Body temperature increased—Tacrolimus—atopic dermatitis	0.000188	0.00205	CcSEcCtD
Pseudoephedrine—Headache—Mometasone—atopic dermatitis	0.000188	0.00204	CcSEcCtD
Pseudoephedrine—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000187	0.00203	CcSEcCtD
Pseudoephedrine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000186	0.00202	CcSEcCtD
Pseudoephedrine—Bradycardia—Betamethasone—atopic dermatitis	0.000182	0.00198	CcSEcCtD
Pseudoephedrine—Bradycardia—Dexamethasone—atopic dermatitis	0.000182	0.00198	CcSEcCtD
Pseudoephedrine—Hallucination—Dexamethasone—atopic dermatitis	0.000178	0.00193	CcSEcCtD
Pseudoephedrine—Hallucination—Betamethasone—atopic dermatitis	0.000178	0.00193	CcSEcCtD
Pseudoephedrine—Nausea—Mometasone—atopic dermatitis	0.000178	0.00193	CcSEcCtD
Pseudoephedrine—Arrhythmia—Triamcinolone—atopic dermatitis	0.000176	0.00191	CcSEcCtD
Pseudoephedrine—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000176	0.00191	CcSEcCtD
Pseudoephedrine—Asthenia—Tacrolimus—atopic dermatitis	0.000171	0.00186	CcSEcCtD
Pseudoephedrine—Vertigo—Prednisolone—atopic dermatitis	0.000168	0.00182	CcSEcCtD
Pseudoephedrine—Vertigo—Hydrocortisone—atopic dermatitis	0.000164	0.00178	CcSEcCtD
Pseudoephedrine—Hypertension—Prednisolone—atopic dermatitis	0.000161	0.00175	CcSEcCtD
Pseudoephedrine—Arrhythmia—Dexamethasone—atopic dermatitis	0.00016	0.00173	CcSEcCtD
Pseudoephedrine—Arrhythmia—Betamethasone—atopic dermatitis	0.00016	0.00173	CcSEcCtD
Pseudoephedrine—Bradycardia—Prednisone—atopic dermatitis	0.000159	0.00172	CcSEcCtD
Pseudoephedrine—Dizziness—Tacrolimus—atopic dermatitis	0.000158	0.00171	CcSEcCtD
Pseudoephedrine—Hypertension—Hydrocortisone—atopic dermatitis	0.000157	0.00171	CcSEcCtD
Pseudoephedrine—Hallucination—Prednisone—atopic dermatitis	0.000155	0.00168	CcSEcCtD
Pseudoephedrine—Anxiety—Hydrocortisone—atopic dermatitis	0.000155	0.00168	CcSEcCtD
Pseudoephedrine—Vertigo—Triamcinolone—atopic dermatitis	0.000154	0.00167	CcSEcCtD
Pseudoephedrine—Vertigo—Methylprednisolone—atopic dermatitis	0.000154	0.00167	CcSEcCtD
Pseudoephedrine—Vomiting—Tacrolimus—atopic dermatitis	0.000152	0.00165	CcSEcCtD
Pseudoephedrine—Rash—Tacrolimus—atopic dermatitis	0.00015	0.00163	CcSEcCtD
Pseudoephedrine—Dermatitis—Tacrolimus—atopic dermatitis	0.00015	0.00163	CcSEcCtD
Pseudoephedrine—Headache—Tacrolimus—atopic dermatitis	0.000149	0.00162	CcSEcCtD
Pseudoephedrine—ADRA2A—head—atopic dermatitis	0.000149	0.0186	CbGeAlD
Pseudoephedrine—Tachycardia—Prednisolone—atopic dermatitis	0.000149	0.00161	CcSEcCtD
Pseudoephedrine—Hypertension—Triamcinolone—atopic dermatitis	0.000148	0.00161	CcSEcCtD
Pseudoephedrine—Hypertension—Methylprednisolone—atopic dermatitis	0.000148	0.0016	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000147	0.0016	CcSEcCtD
Pseudoephedrine—Anxiety—Methylprednisolone—atopic dermatitis	0.000145	0.00158	CcSEcCtD
Pseudoephedrine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000145	0.00158	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000144	0.00156	CcSEcCtD
Pseudoephedrine—Anorexia—Hydrocortisone—atopic dermatitis	0.000142	0.00154	CcSEcCtD
Pseudoephedrine—Nausea—Tacrolimus—atopic dermatitis	0.000142	0.00154	CcSEcCtD
Pseudoephedrine—Confusional state—Methylprednisolone—atopic dermatitis	0.000141	0.00153	CcSEcCtD
Pseudoephedrine—Vertigo—Dexamethasone—atopic dermatitis	0.00014	0.00152	CcSEcCtD
Pseudoephedrine—Vertigo—Betamethasone—atopic dermatitis	0.00014	0.00152	CcSEcCtD
Pseudoephedrine—Arrhythmia—Prednisone—atopic dermatitis	0.000139	0.00151	CcSEcCtD
Pseudoephedrine—Insomnia—Prednisolone—atopic dermatitis	0.000138	0.0015	CcSEcCtD
Pseudoephedrine—Tachycardia—Triamcinolone—atopic dermatitis	0.000137	0.00148	CcSEcCtD
Pseudoephedrine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000136	0.00148	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000135	0.00147	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000135	0.00147	CcSEcCtD
Pseudoephedrine—Insomnia—Hydrocortisone—atopic dermatitis	0.000134	0.00146	CcSEcCtD
Pseudoephedrine—Hypertension—Dexamethasone—atopic dermatitis	0.000134	0.00146	CcSEcCtD
Pseudoephedrine—Hypertension—Betamethasone—atopic dermatitis	0.000134	0.00146	CcSEcCtD
Pseudoephedrine—Anxiety—Dexamethasone—atopic dermatitis	0.000132	0.00143	CcSEcCtD
Pseudoephedrine—Anxiety—Betamethasone—atopic dermatitis	0.000132	0.00143	CcSEcCtD
Pseudoephedrine—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000131	0.00142	CcSEcCtD
Pseudoephedrine—Pain—Prednisolone—atopic dermatitis	0.00013	0.00141	CcSEcCtD
Pseudoephedrine—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000129	0.0014	CcSEcCtD
Pseudoephedrine—Pain—Hydrocortisone—atopic dermatitis	0.000127	0.00138	CcSEcCtD
Pseudoephedrine—Insomnia—Triamcinolone—atopic dermatitis	0.000127	0.00138	CcSEcCtD
Pseudoephedrine—Insomnia—Methylprednisolone—atopic dermatitis	0.000126	0.00137	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Prednisolone—atopic dermatitis	0.000125	0.00136	CcSEcCtD
Pseudoephedrine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000125	0.00136	CcSEcCtD
Pseudoephedrine—Agitation—Prednisone—atopic dermatitis	0.000125	0.00135	CcSEcCtD
Pseudoephedrine—Tachycardia—Betamethasone—atopic dermatitis	0.000124	0.00135	CcSEcCtD
Pseudoephedrine—Tachycardia—Dexamethasone—atopic dermatitis	0.000124	0.00135	CcSEcCtD
Pseudoephedrine—Dyspepsia—Triamcinolone—atopic dermatitis	0.000123	0.00134	CcSEcCtD
Pseudoephedrine—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000123	0.00134	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000123	0.00133	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000123	0.00133	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000123	0.00133	CcSEcCtD
Pseudoephedrine—Vertigo—Prednisone—atopic dermatitis	0.000122	0.00132	CcSEcCtD
Pseudoephedrine—Anorexia—Dexamethasone—atopic dermatitis	0.000121	0.00131	CcSEcCtD
Pseudoephedrine—Anorexia—Betamethasone—atopic dermatitis	0.000121	0.00131	CcSEcCtD
Pseudoephedrine—Pain—Triamcinolone—atopic dermatitis	0.00012	0.0013	CcSEcCtD
Pseudoephedrine—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000118	0.00128	CcSEcCtD
Pseudoephedrine—Hypertension—Prednisone—atopic dermatitis	0.000117	0.00127	CcSEcCtD
Pseudoephedrine—CYP2D6—head—atopic dermatitis	0.000115	0.0144	CbGeAlD
Pseudoephedrine—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000115	0.00125	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000115	0.00125	CcSEcCtD
Pseudoephedrine—Anxiety—Prednisone—atopic dermatitis	0.000115	0.00125	CcSEcCtD
Pseudoephedrine—Insomnia—Dexamethasone—atopic dermatitis	0.000115	0.00125	CcSEcCtD
Pseudoephedrine—Insomnia—Betamethasone—atopic dermatitis	0.000115	0.00125	CcSEcCtD
Pseudoephedrine—Dyspepsia—Dexamethasone—atopic dermatitis	0.000112	0.00121	CcSEcCtD
Pseudoephedrine—Dyspepsia—Betamethasone—atopic dermatitis	0.000112	0.00121	CcSEcCtD
Pseudoephedrine—Body temperature increased—Triamcinolone—atopic dermatitis	0.000111	0.0012	CcSEcCtD
Pseudoephedrine—Decreased appetite—Dexamethasone—atopic dermatitis	0.00011	0.0012	CcSEcCtD
Pseudoephedrine—Decreased appetite—Betamethasone—atopic dermatitis	0.00011	0.0012	CcSEcCtD
Pseudoephedrine—Pain—Dexamethasone—atopic dermatitis	0.000109	0.00118	CcSEcCtD
Pseudoephedrine—Pain—Betamethasone—atopic dermatitis	0.000109	0.00118	CcSEcCtD
Pseudoephedrine—Tachycardia—Prednisone—atopic dermatitis	0.000108	0.00117	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Prednisone—atopic dermatitis	0.000107	0.00116	CcSEcCtD
Pseudoephedrine—Asthenia—Hydrocortisone—atopic dermatitis	0.000107	0.00116	CcSEcCtD
Pseudoephedrine—Anorexia—Prednisone—atopic dermatitis	0.000105	0.00115	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000105	0.00114	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Betamethasone—atopic dermatitis	0.000105	0.00114	CcSEcCtD
Pseudoephedrine—Dizziness—Prednisolone—atopic dermatitis	0.000101	0.00109	CcSEcCtD
Pseudoephedrine—Asthenia—Triamcinolone—atopic dermatitis	0.0001	0.00109	CcSEcCtD
Pseudoephedrine—Body temperature increased—Dexamethasone—atopic dermatitis	0.0001	0.00109	CcSEcCtD
Pseudoephedrine—Body temperature increased—Betamethasone—atopic dermatitis	0.0001	0.00109	CcSEcCtD
Pseudoephedrine—Asthenia—Methylprednisolone—atopic dermatitis	0.0001	0.00109	CcSEcCtD
Pseudoephedrine—Insomnia—Prednisone—atopic dermatitis	0.0001	0.00109	CcSEcCtD
Pseudoephedrine—Dizziness—Hydrocortisone—atopic dermatitis	9.83e-05	0.00107	CcSEcCtD
Pseudoephedrine—Dyspepsia—Prednisone—atopic dermatitis	9.74e-05	0.00106	CcSEcCtD
Pseudoephedrine—Decreased appetite—Prednisone—atopic dermatitis	9.62e-05	0.00104	CcSEcCtD
Pseudoephedrine—Rash—Prednisolone—atopic dermatitis	9.6e-05	0.00104	CcSEcCtD
Pseudoephedrine—Dermatitis—Prednisolone—atopic dermatitis	9.59e-05	0.00104	CcSEcCtD
Pseudoephedrine—Headache—Prednisolone—atopic dermatitis	9.54e-05	0.00104	CcSEcCtD
Pseudoephedrine—Vomiting—Hydrocortisone—atopic dermatitis	9.45e-05	0.00103	CcSEcCtD
Pseudoephedrine—Rash—Hydrocortisone—atopic dermatitis	9.38e-05	0.00102	CcSEcCtD
Pseudoephedrine—Dermatitis—Hydrocortisone—atopic dermatitis	9.37e-05	0.00102	CcSEcCtD
Pseudoephedrine—Headache—Hydrocortisone—atopic dermatitis	9.32e-05	0.00101	CcSEcCtD
Pseudoephedrine—Dizziness—Triamcinolone—atopic dermatitis	9.26e-05	0.00101	CcSEcCtD
Pseudoephedrine—Dizziness—Methylprednisolone—atopic dermatitis	9.24e-05	0.001	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Prednisone—atopic dermatitis	9.12e-05	0.00099	CcSEcCtD
Pseudoephedrine—Asthenia—Betamethasone—atopic dermatitis	9.11e-05	0.00099	CcSEcCtD
Pseudoephedrine—Asthenia—Dexamethasone—atopic dermatitis	9.11e-05	0.00099	CcSEcCtD
Pseudoephedrine—Nausea—Prednisolone—atopic dermatitis	9.04e-05	0.000982	CcSEcCtD
Pseudoephedrine—Vomiting—Triamcinolone—atopic dermatitis	8.9e-05	0.000967	CcSEcCtD
Pseudoephedrine—Vomiting—Methylprednisolone—atopic dermatitis	8.88e-05	0.000964	CcSEcCtD
Pseudoephedrine—Nausea—Hydrocortisone—atopic dermatitis	8.83e-05	0.000959	CcSEcCtD
Pseudoephedrine—Rash—Triamcinolone—atopic dermatitis	8.83e-05	0.000959	CcSEcCtD
Pseudoephedrine—Dermatitis—Triamcinolone—atopic dermatitis	8.82e-05	0.000958	CcSEcCtD
Pseudoephedrine—Rash—Methylprednisolone—atopic dermatitis	8.81e-05	0.000956	CcSEcCtD
Pseudoephedrine—Dermatitis—Methylprednisolone—atopic dermatitis	8.8e-05	0.000956	CcSEcCtD
Pseudoephedrine—Headache—Triamcinolone—atopic dermatitis	8.77e-05	0.000952	CcSEcCtD
Pseudoephedrine—Headache—Methylprednisolone—atopic dermatitis	8.75e-05	0.00095	CcSEcCtD
Pseudoephedrine—Body temperature increased—Prednisone—atopic dermatitis	8.75e-05	0.00095	CcSEcCtD
Pseudoephedrine—Dizziness—Betamethasone—atopic dermatitis	8.4e-05	0.000912	CcSEcCtD
Pseudoephedrine—Dizziness—Dexamethasone—atopic dermatitis	8.4e-05	0.000912	CcSEcCtD
Pseudoephedrine—Nausea—Triamcinolone—atopic dermatitis	8.32e-05	0.000903	CcSEcCtD
Pseudoephedrine—Nausea—Methylprednisolone—atopic dermatitis	8.3e-05	0.000901	CcSEcCtD
Pseudoephedrine—Vomiting—Betamethasone—atopic dermatitis	8.08e-05	0.000877	CcSEcCtD
Pseudoephedrine—Vomiting—Dexamethasone—atopic dermatitis	8.08e-05	0.000877	CcSEcCtD
Pseudoephedrine—Rash—Dexamethasone—atopic dermatitis	8.01e-05	0.00087	CcSEcCtD
Pseudoephedrine—Rash—Betamethasone—atopic dermatitis	8.01e-05	0.00087	CcSEcCtD
Pseudoephedrine—Dermatitis—Dexamethasone—atopic dermatitis	8e-05	0.000869	CcSEcCtD
Pseudoephedrine—Dermatitis—Betamethasone—atopic dermatitis	8e-05	0.000869	CcSEcCtD
Pseudoephedrine—Headache—Dexamethasone—atopic dermatitis	7.96e-05	0.000864	CcSEcCtD
Pseudoephedrine—Headache—Betamethasone—atopic dermatitis	7.96e-05	0.000864	CcSEcCtD
Pseudoephedrine—Asthenia—Prednisone—atopic dermatitis	7.94e-05	0.000862	CcSEcCtD
Pseudoephedrine—Nausea—Dexamethasone—atopic dermatitis	7.55e-05	0.000819	CcSEcCtD
Pseudoephedrine—Nausea—Betamethasone—atopic dermatitis	7.55e-05	0.000819	CcSEcCtD
Pseudoephedrine—Dizziness—Prednisone—atopic dermatitis	7.32e-05	0.000794	CcSEcCtD
Pseudoephedrine—Vomiting—Prednisone—atopic dermatitis	7.03e-05	0.000764	CcSEcCtD
Pseudoephedrine—Rash—Prednisone—atopic dermatitis	6.98e-05	0.000757	CcSEcCtD
Pseudoephedrine—Dermatitis—Prednisone—atopic dermatitis	6.97e-05	0.000757	CcSEcCtD
Pseudoephedrine—Headache—Prednisone—atopic dermatitis	6.93e-05	0.000753	CcSEcCtD
Pseudoephedrine—Nausea—Prednisone—atopic dermatitis	6.57e-05	0.000714	CcSEcCtD
Pseudoephedrine—IL2—Immune System—CASP8—atopic dermatitis	2.65e-05	0.000199	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CCR5—atopic dermatitis	2.65e-05	0.000199	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FCER2—atopic dermatitis	2.63e-05	0.000197	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCL11—atopic dermatitis	2.61e-05	0.000196	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CCL5—atopic dermatitis	2.57e-05	0.000193	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD4—atopic dermatitis	2.57e-05	0.000193	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FCER2—atopic dermatitis	2.57e-05	0.000193	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	2.54e-05	0.000191	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—CXCL8—atopic dermatitis	2.53e-05	0.00019	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CCL5—atopic dermatitis	2.52e-05	0.000189	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—TNF—atopic dermatitis	2.52e-05	0.000189	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CCL5—atopic dermatitis	2.49e-05	0.000187	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL17—atopic dermatitis	2.49e-05	0.000187	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.48e-05	0.000186	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—IL6—atopic dermatitis	2.48e-05	0.000186	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.46e-05	0.000185	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL22—atopic dermatitis	2.44e-05	0.000183	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CXCL10—atopic dermatitis	2.42e-05	0.000182	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—PPARA—atopic dermatitis	2.4e-05	0.00018	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CCR3—atopic dermatitis	2.39e-05	0.00018	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL22—atopic dermatitis	2.39e-05	0.000179	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—IL6—atopic dermatitis	2.39e-05	0.000179	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL1B—atopic dermatitis	2.38e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CD4—atopic dermatitis	2.38e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL2—atopic dermatitis	2.37e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL5—atopic dermatitis	2.36e-05	0.000177	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	2.35e-05	0.000176	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CCR3—atopic dermatitis	2.34e-05	0.000176	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CCR5—atopic dermatitis	2.32e-05	0.000174	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NGF—atopic dermatitis	2.3e-05	0.000173	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—CXCL8—atopic dermatitis	2.29e-05	0.000172	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.29e-05	0.000172	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CCR5—atopic dermatitis	2.27e-05	0.00017	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IFNG—atopic dermatitis	2.25e-05	0.000169	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CXCL10—atopic dermatitis	2.25e-05	0.000169	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NFKBIA—atopic dermatitis	2.25e-05	0.000169	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CCR5—atopic dermatitis	2.24e-05	0.000168	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—MAPK8—atopic dermatitis	2.18e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL27—atopic dermatitis	2.18e-05	0.000163	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD4—atopic dermatitis	2.18e-05	0.000163	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCR3—atopic dermatitis	2.17e-05	0.000163	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCL11—atopic dermatitis	2.16e-05	0.000162	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.14e-05	0.000161	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—TAC1—atopic dermatitis	2.13e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—NPS—atopic dermatitis	2.13e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL27—atopic dermatitis	2.13e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FCER2—atopic dermatitis	2.13e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCR3—atopic dermatitis	2.13e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCR3—atopic dermatitis	2.09e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—TAC1—atopic dermatitis	2.09e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—NPS—atopic dermatitis	2.09e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CCL5—atopic dermatitis	2.08e-05	0.000156	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCR3—atopic dermatitis	2.05e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.03e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.03e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—IL6—atopic dermatitis	2.02e-05	0.000152	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL1B—atopic dermatitis	2.01e-05	0.000151	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL11—atopic dermatitis	2e-05	0.00015	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL5—atopic dermatitis	1.98e-05	0.000149	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL22—atopic dermatitis	1.98e-05	0.000148	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FCER2—atopic dermatitis	1.98e-05	0.000148	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL17—atopic dermatitis	1.95e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL5—atopic dermatitis	1.94e-05	0.000146	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TAC1—atopic dermatitis	1.94e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—NPS—atopic dermatitis	1.94e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CCR3—atopic dermatitis	1.94e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CCL5—atopic dermatitis	1.94e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL17—atopic dermatitis	1.91e-05	0.000143	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NFKBIA—atopic dermatitis	1.9e-05	0.000143	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCR3—atopic dermatitis	1.9e-05	0.000143	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TAC1—atopic dermatitis	1.89e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—NPS—atopic dermatitis	1.89e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CCR5—atopic dermatitis	1.88e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GLB1—atopic dermatitis	1.87e-05	0.00014	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCR3—atopic dermatitis	1.86e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—MAPK8—atopic dermatitis	1.84e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.84e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL22—atopic dermatitis	1.84e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.8e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.8e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL5—atopic dermatitis	1.8e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CCR3—atopic dermatitis	1.8e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ADSL—atopic dermatitis	1.79e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL27—atopic dermatitis	1.76e-05	0.000132	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL5—atopic dermatitis	1.76e-05	0.000132	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCR3—atopic dermatitis	1.76e-05	0.000132	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	1.75e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CCR5—atopic dermatitis	1.74e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.74e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KIF3A—atopic dermatitis	1.74e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—TAC1—atopic dermatitis	1.73e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—NPS—atopic dermatitis	1.73e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KIF3A—atopic dermatitis	1.7e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCR3—atopic dermatitis	1.69e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCL10—atopic dermatitis	1.69e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCL10—atopic dermatitis	1.65e-05	0.000124	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL27—atopic dermatitis	1.64e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCR3—atopic dermatitis	1.63e-05	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL5—atopic dermatitis	1.6e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TAC1—atopic dermatitis	1.6e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—NPS—atopic dermatitis	1.6e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CXCL8—atopic dermatitis	1.6e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL17—atopic dermatitis	1.58e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL11—atopic dermatitis	1.57e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CMA1—atopic dermatitis	1.57e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCR3—atopic dermatitis	1.57e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TAC1—atopic dermatitis	1.57e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—NPS—atopic dermatitis	1.57e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CMA1—atopic dermatitis	1.54e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL11—atopic dermatitis	1.54e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCR3—atopic dermatitis	1.54e-05	0.000115	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCL10—atopic dermatitis	1.53e-05	0.000115	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL2—atopic dermatitis	1.53e-05	0.000115	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCL10—atopic dermatitis	1.5e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL5—atopic dermatitis	1.49e-05	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.49e-05	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—STAT6—atopic dermatitis	1.48e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL17—atopic dermatitis	1.47e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL5—atopic dermatitis	1.46e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TAC1—atopic dermatitis	1.46e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—NPS—atopic dermatitis	1.46e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CCL5—atopic dermatitis	1.45e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—STAT6—atopic dermatitis	1.45e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCR3—atopic dermatitis	1.43e-05	0.000107	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CCL5—atopic dermatitis	1.42e-05	0.000107	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MAPK8—atopic dermatitis	1.41e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KIF3A—atopic dermatitis	1.41e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—CXCL8—atopic dermatitis	1.4e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL6—atopic dermatitis	1.39e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.38e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—CXCL8—atopic dermatitis	1.37e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.37e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CXCL8—atopic dermatitis	1.35e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL5—atopic dermatitis	1.35e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCL5—atopic dermatitis	1.32e-05	9.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CCR5—atopic dermatitis	1.31e-05	9.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KIF3A—atopic dermatitis	1.31e-05	9.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCL5—atopic dermatitis	1.29e-05	9.7e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—IL6—atopic dermatitis	1.29e-05	9.67e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—IL6—atopic dermatitis	1.28e-05	9.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCR3—atopic dermatitis	1.28e-05	9.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CCR5—atopic dermatitis	1.28e-05	9.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL11—atopic dermatitis	1.27e-05	9.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CMA1—atopic dermatitis	1.27e-05	9.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.27e-05	9.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCR3—atopic dermatitis	1.26e-05	9.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCL10—atopic dermatitis	1.24e-05	9.32e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GLB1—atopic dermatitis	1.22e-05	9.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—STAT6—atopic dermatitis	1.2e-05	8.99e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MAPK8—atopic dermatitis	1.19e-05	8.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCR5—atopic dermatitis	1.19e-05	8.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL11—atopic dermatitis	1.18e-05	8.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CMA1—atopic dermatitis	1.18e-05	8.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CCL5—atopic dermatitis	1.18e-05	8.84e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL6—atopic dermatitis	1.18e-05	8.84e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ADSL—atopic dermatitis	1.17e-05	8.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCR5—atopic dermatitis	1.16e-05	8.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL10—atopic dermatitis	1.15e-05	8.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NPS—atopic dermatitis	1.14e-05	8.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TAC1—atopic dermatitis	1.14e-05	8.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—CXCL8—atopic dermatitis	1.13e-05	8.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.13e-05	8.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCR3—atopic dermatitis	1.12e-05	8.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TAC1—atopic dermatitis	1.12e-05	8.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NPS—atopic dermatitis	1.12e-05	8.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—STAT6—atopic dermatitis	1.11e-05	8.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCR3—atopic dermatitis	1.1e-05	8.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CCL5—atopic dermatitis	1.09e-05	8.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCL5—atopic dermatitis	1.07e-05	8.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL5—atopic dermatitis	1.06e-05	7.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CCR5—atopic dermatitis	1.06e-05	7.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CXCL8—atopic dermatitis	1.05e-05	7.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL5—atopic dermatitis	1.04e-05	7.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCR3—atopic dermatitis	1.04e-05	7.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	9.93e-06	7.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	9.85e-06	7.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	9.65e-06	7.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCR5—atopic dermatitis	9.63e-06	7.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NPS—atopic dermatitis	9.26e-06	6.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TAC1—atopic dermatitis	9.26e-06	6.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCR3—atopic dermatitis	9.08e-06	6.81e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PPARA—atopic dermatitis	9.07e-06	6.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL10—atopic dermatitis	9.07e-06	6.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL2—atopic dermatitis	9.01e-06	6.76e-05	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL6—atopic dermatitis	9e-06	6.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	8.95e-06	6.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL10—atopic dermatitis	8.87e-06	6.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	8.6e-06	6.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	8.6e-06	6.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	8.6e-06	6.46e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—IL6—atopic dermatitis	8.51e-06	6.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	8.43e-06	6.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	7.99e-06	6e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCL8—atopic dermatitis	7.92e-06	5.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL5—atopic dermatitis	7.81e-06	5.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCL8—atopic dermatitis	7.75e-06	5.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL5—atopic dermatitis	7.64e-06	5.73e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL6—atopic dermatitis	7.61e-06	5.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL2—atopic dermatitis	7.57e-06	5.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL2—atopic dermatitis	7.41e-06	5.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	7.34e-06	5.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NGF—atopic dermatitis	7.23e-06	5.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	7.2e-06	5.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NGF—atopic dermatitis	7.07e-06	5.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCL8—atopic dermatitis	7.04e-06	5.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	7.03e-06	5.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCR5—atopic dermatitis	6.88e-06	5.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	6.88e-06	5.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	6.82e-06	5.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL2—atopic dermatitis	6.73e-06	5.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	6.41e-06	4.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	6.32e-06	4.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	6.13e-06	4.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARA—atopic dermatitis	6.06e-06	4.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	5.96e-06	4.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	5.96e-06	4.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	5.87e-06	4.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	5.85e-06	4.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NFKBIA—atopic dermatitis	5.83e-06	4.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	5.82e-06	4.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	5.69e-06	4.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	5.69e-06	4.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	5.56e-06	4.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	5.43e-06	4.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	5.41e-06	4.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	5.29e-06	3.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	5.17e-06	3.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	4.82e-06	3.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	4.48e-06	3.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	4.25e-06	3.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL8—atopic dermatitis	4.16e-06	3.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2—atopic dermatitis	4.06e-06	3.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	4.04e-06	3.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2—atopic dermatitis	3.97e-06	2.98e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—atopic dermatitis	3.95e-06	2.97e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARA—atopic dermatitis	3.95e-06	2.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	3.74e-06	2.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MAPK8—atopic dermatitis	3.66e-06	2.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	3.44e-06	2.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	3.29e-06	2.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	3.27e-06	2.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	3.2e-06	2.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	3.05e-06	2.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	3.04e-06	2.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	3.03e-06	2.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	2.81e-06	2.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—atopic dermatitis	2.39e-06	1.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—atopic dermatitis	2.34e-06	1.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	1.93e-06	1.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	1.8e-06	1.35e-05	CbGpPWpGaD
